Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research

Bausch Health’s (TSX:BHC) DEXAVEN Gets Polish Drug Regulator Grant For COVID-19 Treatment

December 30, 2020 09:18 AM EST | By Team Kalkine Media
Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Recent News

thumbnail

Is Exchange Income (TSX:EIF) Showing Momentum On The S&P/TSX Composite...

thumbnail

Is Manulife Financial (TSX:MFC) Gaining Attention On S&P/TSX Composite...

thumbnail

Is Sherritt International (TSX:S) Gaining Traction On The S&P/TSX Comp...

thumbnail

Is Chorus Aviation (TSX:CHR) On S&P/TSX Composite Index And S&P/TSX Co...

 

  • Bausch Health announced that it has received an additional new indication from the drug regulator in Poland for its DEXAVEN shot, for the treatment of COVID-19 in adult and adolescent patients who need oxygen therapy.
  • DEXAVEN (dexamethasone phosphate) is a corticosteroid that decreases inflammation.
  • The healthcare company continues to test its drugs across the world to find out if it may reach a breakthrough to provide more treatment options for SARS-CoV-2. However, Dexamethasone-based drugs have failed to receive the US FDA’s approval.
  • The Laval-based pharmaceutical company’s stocks have soared over 23 per cent in the last three months. The drug manufacturer has nearly 355 million issued shares on the Toronto Stock Exchange (TSX). Its current market cap stands at approximately C$ 9 billion. The stock has a price-to-book (P/B) ratio of 11.958 and a present price-to-cashflow ratio of 7.50, as per the TMX portal.
  • The stock’s debt-to-equity is 41.47; however, the company announced on December 29 through its exchange filing that they will pay all its debt or mandatory amortization payments by 2024. The drug maker is expected to repay nearly C$ 900 million of debt this year.

 

 

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

CA_Premium_Article

Sponsored Articles

1

Explained: What is SpendTheBits merchant portal and how to use it

2

Benefits of using SpendTheBits app for users and retail merchants

3

An overview of SpendTheBits’ decentralized merchant solution for BTC &...

4

Is investing art or science? KB Crypto has the answer

5

5 factors that make KB Crypto stand out in crypto hedge fund space

Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.